News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Genetic Medicine. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
Northwestern and Cell Press hosted a symposium on transcriptional regulation, welcoming more than 350 attendees from around the world.
Evangelos Kiskinis, PhD, has received a New York Stem Cell Foundation – Robertson Investigator Award to study the origins of ALS and pediatric epilepsy.
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
A new blood test can identify early-stage liver cancer, allowing clinicians to start treatment early, according to a new study.
A molecule drastically reduced toxic proteins in human neuron cells with Huntington’s disease, representing a potential therapy for the deadly degenerative disease, according to a new study.
A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.
Scientists have identified a new gene that can inhibit a multi-protein complex, possibly increasing the risk of cancer, according to a new study published in Science Advances.
Slowing mutant fruit flies’ metabolic rates can prevent detrimental effects of many genetic mutations, according a new study published in the journal Cell.
A new study published in Developmental Cell discovered a link between a previously unknown mitochondrial process and Charcot-Marie-Tooth disease Type 2, a genetic neuropathy.
Feinberg partnered with Nature Genetics and Nature Medicine to host the Chicago Science 2019: Epigenetics and Genome Editing conference.
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, has been named a Pew Biomedical Scholar.
Low- and moderate-intensity exercise improved muscle, heart and breathing function in an animal model of Duchenne muscular dystrophy, according to a Northwestern Medicine study.
Northwestern scientists have discovered how certain genetic mutations can weaken protein “quality control,” identifying a pathway that may contribute to neurodegenerative diseases.
A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
Northwestern scientists have identified a new function for a transcription factor called BCL6, finding that it switches off genes involved in lipid metabolism.
A gene involved in male hormone production plays a major role in the development of polycystic ovary syndrome, according to a recent study.
A team of scientists has identified new genetic regions associated with asthma in people of African ancestry, according to a study published in Nature Communications.
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
Scientists identified over 500 genetic variants associated with tobacco or alcohol use, in a genome-wide association study recently published in Nature Genetics.
A genome-wide analysis revealed nine new genes associated with fragile X syndrome, findings that shed light on the complex hereditary mechanisms behind the genetic disease.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
Elizabeth McNally, MD, PhD, has been elected as a fellow of the National Academy of Inventors, joining more than 900 other inventors, who were selected for prolific innovations that improve quality of life or economic development.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
A recent study found that stability of chromatin structures across DNA replication requires cooperation between a histone chaperone and DNA replication machinery; a mechanism of epigenetic inheritance.